Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
205.45
-0.1 (-0.05%)
BSENSE

Jun 10, 03:30 PM

BSE+NSE Vol: 2.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Sakar Healthcare
Venus Remedies
NGL Fine Chem
Kwality Pharma
Hester Bios
Amrutanjan Healt
Windlas Biotech
Unichem Labs.
Hikal
Indoco Remedies
Sai Parenteral's

Why is Indoco Remedies Ltd ?

1
Weak Long Term Fundamental Strength with a -36.71% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.69 times
  • The company has been able to generate a Return on Equity (avg) of 7.83% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 14 consecutive quarters
  • DEBT-EQUITY RATIO(HY) Highest at 1.16 times
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.67 times
  • INTEREST(Q) Highest at Rs 45.92 cr
3
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -29.01% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Indoco Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Indoco Remedies
-29.01%
-0.66
44.01%
Sensex
-10.21%
-0.78
13.06%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
8.25%
EBIT Growth (5y)
-36.71%
EBIT to Interest (avg)
6.02
Debt to EBITDA (avg)
4.43
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.08
Tax Ratio
7.33%
Dividend Payout Ratio
14.04%
Pledged Shares
0
Institutional Holding
19.09%
ROCE (avg)
10.05%
ROE (avg)
7.83%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
2.02
EV to EBIT
192.39
EV to EBITDA
20.83
EV to Capital Employed
1.48
EV to Sales
1.60
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
0.77%
ROE (Latest)
-9.82%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
PBDIT(Q)

Highest at Rs 49.71 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 10.45%

-13What is not working for the Company
DEBT-EQUITY RATIO(HY)

Highest at 1.16 times

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.67 times

INTEREST(Q)

Highest at Rs 45.92 cr

Loading Valuation Snapshot...

Here's what is working for Indoco Remedies

Operating Profit (PBDIT) - Quarterly
Highest at Rs 49.71 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 10.45%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Here's what is not working for Indoco Remedies

Interest - Quarterly
At Rs 45.92 cr has Grown at 79.10%
Quarter on Quarter (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debt-Equity Ratio - Half Yearly
Highest at 1.16 times and Grown
each half year in the last five half yearly periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest - Quarterly
Highest at Rs 45.92 cr
in the last five quarters and Increased by 79.10 % (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 3.67 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio